COST PLUS FIXED FEE

LEIDOS BIOMEDICAL RESEARCH INC - CHARACTERIZING THE MECHANISM OF ACTION (MOA) OF INVESTIGATIONAL/APPROVED CANCER AGENTS

PIID: 75N91023F00019
Signed Date: Dec 8, 2025Effective Date: Sep 22, 2023End Date: Closes in 832 days
Award $
$4.6M
Vendor
LEIDOS BIOMEDICAL RESEARCH INC
NAICS
541715
Signed Date
Dec 8, 2025

Key Details

Dollars Obligated
$4.6M
Base & All Options
$-1,090,912
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
FREDERICK, MD, 217015213, CD-MD-06

Description

CHARACTERIZING THE MECHANISM OF ACTION (MOA) OF INVESTIGATIONAL/APPROVED CANCER AGENTS

Context & Analysis

On Dec 8, 2025, Department of Health and Human Services obligated $4,568,362 to LEIDOS BIOMEDICAL RESEARCH INC for characterizing the mechanism of action (moa) of investigational/approved cancer agents. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Sep 21, 2028.

Contractor Information

UEI: HV8BH9BPG8Y9
CAGE Code: 3LYK6
Location: FREDERICK, MD
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related